APA (7th ed.) Citation

Sievers, P., Stichel, D., Sill, M., Schrimpf, D., Sturm, D., Selt, F., . . . Sahm, F. (2021). GOPC: ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types. Acta neuropathologica, 142(6), . https://doi.org/10.1007/s00401-021-02369-1

Chicago Style (17th ed.) Citation

Sievers, Philipp, et al. "GOPC: ROS1 and Other ROS1 Fusions Represent a Rare but Recurrent Drug Target in a Variety of Glioma Types." Acta Neuropathologica 142, no. 6 (2021). https://doi.org/10.1007/s00401-021-02369-1.

MLA (9th ed.) Citation

Sievers, Philipp, et al. "GOPC: ROS1 and Other ROS1 Fusions Represent a Rare but Recurrent Drug Target in a Variety of Glioma Types." Acta Neuropathologica, vol. 142, no. 6, 2021, https://doi.org/10.1007/s00401-021-02369-1.